San Diego County News

Independent publication serving San Diego County

  • Local
    • Central San Diego
    • North County
    • East County
    • South Bay
    • Northeastern
    • Temecula
  • Entertainment
    • Music
    • Television
    • Art
    • Theater
    • Film
    • Events
    • Theme Parks
    • Podcast/Radio
    • Museums
    • Books
  • Business
  • National
  • Politics
  • Sports
  • Health
    • Health Business
    • Health Education
    • Medical
  • Lifestyle
    • Travel
    • Food
    • Lifestyle
    • Senior Life
    • Society
  • Commentary
  • Home

Antidepressants as treatment immediately following a stroke?

April 13, 2010 By Staff

(Newswise)–A study in rodents shows the growth of new neurons, also known as neurogenesis, lessens the severity of stroke and dramatically improves function following a stroke. The research, undertaken at the Buck Institute for Age Research, suggests that drugs shown to promote neurogenesis in rodents could have benefits for human stroke victims and that those drugs–which include antidepressants and mood stabilizers such as lithium–may be suitable for study in human clinical trials. Results of the research appear the week of April 12 in the online edition of The Proceedings of the National Academy of Sciences.

“What this study shows more convincingly than in the past is that the production of new neurons after stroke is beneficial in rodents,” said Buck faculty member and senior author David Greenberg, MD, PhD. “Assuming that neurogenesis is also beneficial in humans, drugs approved by the FDA for other purposes and already shown to promote new neuron growth in rodents might be worth studying as a potential treatment for stroke in humans. For example, antidepressants are often used to treat post-stroke depression, but their potential for improving outcome from stroke itself is less certain.” Previous research by the same group at the Buck Institute, which includes Drs. Kunlin Jin, Xiaomei Wang, Lin Xie and Xiao Mao, showed that the brain attempts to heal itself following stroke by growing new neurons, but it has not been shown clearly that those new neurons improve function.

Trending
Man suspected of stabbing parents arrested in Vista

About 795,000 Americans suffer a stroke each year. Stroke is the third leading cause of death in the U.S. and is the leading cause of serious long-term disability in this country. Treatments for stroke are limited. Clot busting drugs, which have to be given within hours of the stroke, have been of great benefit to a small number of patients, but stroke is not usually diagnosed in time for them to be used.

The Buck Institute study, which did not involve screening any of the existing drugs that support neurogenesis, compared stroke size and recovery in mice who were genetically altered and treated to either grow or not grow new neurons prior to stroke. Greenberg says strokes were about 30 percent larger in the animals that did not grow new neurons; the rodents that did grow new neurons showed dramatic improvement in motor function following the stroke. The exact mechanism by which the new neurons improve outcome is unknown.

Greenberg says future research at the Buck will likely involve testing drugs that stimulate neurogenesis at various dosages and treatment times to see if they improve outcome following stroke in rodents. Building on the Institute’s collaborative approach to research involving other age-related disorders, Greenberg says its also likely that the impact of the growth of new neurons will be examined in animal models of Alzheimer’s, Parkinson’s and Huntington’s disease.

Although the possibility of using existing drugs for the treatment of stroke is one that may excite patients and patient advocates, Greenberg urges caution. He says those suffering from stroke should not treat themselves, even with FDA-approved drugs, without medical advice. “Everything has potential side effects,” said Greenberg. “Even taking something as seemingly innocuous as an antidepressant carries the possibility of making someone worse. These drugs need to be tested in a controlled clinical setting.”

40

SHARES
Share on Facebook
Tweet
Follow us

Comments

comments

Filed Under: Health, Medical


Support Independent Journalism



Environment

EPA proposes to strengthen air quality standards

January 7, 2023 By sdcnews

Science & Technology

Little rodent, big appetite

December 22, 2022 By sdcnews

Advertisement

Start planning your Travel Tuesday getaway! Just enter code TRAVELT35 for up to $35 off our fees on flights and be ready to take off.

Trending

School Sports

Animal News

Helen Woodward Animal Center meets UN Council

December 22, 2022 By sdcnews

Community Events

Things To Do

Categories

  • About Us
  • Archive
  • Contact Us
  • Private Policy
  • Terms of Service
  • Things To Do

Follow @SanCounty

Privacy Policy

Terms of service

Copyright © 2023 San Diego County News